share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4：持股變動聲明-高管 Kupiec James William
美股sec公告 ·  04/22 21:20
牛牛AI助理已提取核心訊息
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
木薯科學首席醫學官詹姆斯·威廉·庫皮克於2024年4月18日完成了對1,500股普通股的購買。該交易以每股22.00美元的價格進行，總投資爲33,000美元。此次收購後，庫皮克在該公司的直接持股量增加到4,000股。該交易被報告爲衍生證券的行使或轉換，這表明高管對公司未來的信心可能會增強。
木薯科學首席醫學官詹姆斯·威廉·庫皮克於2024年4月18日完成了對1,500股普通股的購買。該交易以每股22.00美元的價格進行，總投資爲33,000美元。此次收購後，庫皮克在該公司的直接持股量增加到4,000股。該交易被報告爲衍生證券的行使或轉換，這表明高管對公司未來的信心可能會增強。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。